Belvedere Trading »

Terns Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-09-30 $183k 37k 5.03
2023-06-30 $322k 37k 8.75

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Vivo Capital
VR Adviser
Braidwell
Franklin Resources
Vanguard Group
Fairmount Funds Management
Millennium Management
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Decheng Capital
Norges Bank Investment Management
Schonfeld Strategic Advisors
Russell Investments

View all funds holding Terns Pharmaceuticals